Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で53.75%の成長率を示しています。
割安
同社の最新のPEは-16.84で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は70.44M株で、前四半期比で0.43%減少しています。
キャサリン・ウッドが保有
スター投資家キャサリン・ウッドは本銘柄を6.40M株保有しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は0.78です。